2021
American Society for Microbiology Presentation
Expectations of chemical decontamination measures for medical instrumentation and surfaces in hospitals have been eroded by accumulating evidence t...
Read more
2021
2021 OSAP Conference: Organization for Safety Asepsis Prevention
Briotech Chief Science Officer, Jeff Williams, PhD, BVSc, MRCVS, and Professor Lori Robins, PhD, Dept. of Physical Sciences at UW, present breakthr...
Read more
2019
Briotech, UW Bothell, & PennState Present HPV & Oropharyngeal Cancer Research
Results: HOCl treatment contact times generally and quickly produced >99.99% reduction in infectivity of HPV16 and HPV18, comparable to the effi...
Read more
2019
PennState Presents the Effectiveness of BrioHOCl™ Against HPV — Geneva, Switzerland
Dr. Craig Meyers, PennState Cancer Institute, presents an HPV abstract on the results of efficacy testing of BrioHOClâ„¢ against high-risk HPV16 and ...
Read more
2017
UW Bothell Presents Briotech at American Chemistry Society Conference
University of Washington, Bothell, presents Briotech's breakthrough in hypochlorous acid stability to the world’s largest scientific body in Washin...
Read more
2016
Students Aid in Breakthrough Against Dementia
The efficacy of the Briotech product is particularly interesting in light of research that suggests neurological diseases, including Alzheimer’s, c...
Read more
2016
Briotech Breakthrough with Prestigious NIH/RML Laboratories
The scientists determined that BrioHOClâ„¢ eliminated all detectable prion-seeding activity for CJD, bovine spongiform encephalopathy (BSE, or mad co...
Read more
2016
Briotech Tackles Deadly Prions
Briotech's unique formulation of pure hypochlorous acid (HOCl) inactivates infectious proteins, known as prions, that cause chronic brain diseases ...
Read more
2016
Briotech Published in PLOS Pathogen
Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid:Â We have tested the anti-prion activity of (BrioHOClâ„¢) that poses no apparent hazar...
Read more